{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:47:43Z","timestamp":1792680463960,"version":"4.5.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 AI144462-07"],"award-info":[{"award-number":["UM1 AI144462-07"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R33 AI161297"],"award-info":[{"award-number":["R33 AI161297"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 AI144462-07"],"award-info":[{"award-number":["UM1 AI144462-07"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R33 AI161297"],"award-info":[{"award-number":["R33 AI161297"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 AI144462-07"],"award-info":[{"award-number":["UM1 AI144462-07"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004095","name":"Kyowa Hakko Kirin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008227","name":"Achievement Rewards for College Scientists Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41590-026-02549-9","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T09:21:06Z","timestamp":1782206466000},"page":"1476-1489","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Rapid boosting increases germinal center responses to sequential vaccines"],"prefix":"10.1038","volume":"27","author":[{"given":"Sonya","family":"Haupt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3364-3083","authenticated-orcid":false,"given":"Christopher A.","family":"Cottrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoya","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Liguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nushin","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2340-3377","authenticated-orcid":false,"given":"Danny","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Phelps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Goodwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elana","family":"Ben-Akiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes A.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8637-1405","authenticated-orcid":false,"given":"Darrell J.","family":"Irvine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1120-0150","authenticated-orcid":false,"given":"William R.","family":"Schief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6484-6262","authenticated-orcid":false,"given":"Shane","family":"Crotty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"2549_CR1","unstructured":"Global HIV & AIDS Statistics\u2014Fact Sheet. UNAIDS https:\/\/www.unaids.org\/en\/resources\/fact-sheet (2024)."},{"key":"2549_CR2","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.chom.2019.08.014","volume":"26","author":"A Pegu","year":"2019","unstructured":"Pegu, A. et al. A meta-analysis of passive immunization studies shows that serum-neutralizing antibody titer associates with protection against SHIV Challenge. Cell Host Microbe 26, 336\u2013346 (2019).","journal-title":"Cell Host Microbe"},{"key":"2549_CR3","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1056\/NEJMoa2031738","volume":"384","author":"L Corey","year":"2021","unstructured":"Corey, L. et al. Two randomized trials of neutralizing antibodies to prevent HIV-1 acquisition. New Engl. J. Med. 384, 1003\u20131014 (2021).","journal-title":"New Engl. J. Med."},{"key":"2549_CR4","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1146\/annurev-immunol-041015-055515","volume":"34","author":"DR Burton","year":"2016","unstructured":"Burton, D. R. & Hangartner, L. Broadly neutralizing antibodies to HIV and their role in vaccine design. Annu. Rev. Immunol. 34, 635\u2013659 (2016).","journal-title":"Annu. Rev. Immunol."},{"key":"2549_CR5","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/s41590-018-0235-7","volume":"19","author":"D Sok","year":"2018","unstructured":"Sok, D. & Burton, D. R. Recent progress in broadly neutralizing antibodies to HIV. Nat. Immunol. 19, 1179\u20131188 (2018).","journal-title":"Nat. Immunol."},{"key":"2549_CR6","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.immuni.2018.04.029","volume":"48","author":"PD Kwong","year":"2018","unstructured":"Kwong, P. D. & Mascola, J. R. HIV-1 vaccines based on antibody identification, B cell ontogeny, and epitope structure. Immunity 48, 855\u2013871 (2018).","journal-title":"Immunity"},{"key":"2549_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaz2686","volume":"11","author":"BF Haynes","year":"2019","unstructured":"Haynes, B. F., Burton, D. R. & Mascola, J. R. Multiple roles for HIV broadly neutralizing antibodies. Sci. Transl. Med. 11, eaaz2686 (2019).","journal-title":"Sci. Transl. Med."},{"key":"2549_CR8","doi-asserted-by":"publisher","first-page":"101470","DOI":"10.1016\/j.smim.2021.101470","volume":"51","author":"JH Lee","year":"2021","unstructured":"Lee, J. H. & Crotty, S. HIV vaccinology: 2021 update. Semin. Immunol. 51, 101470 (2021).","journal-title":"Semin. Immunol."},{"key":"2549_CR9","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3390\/vaccines12091043","volume":"12","author":"R Govindan","year":"2024","unstructured":"Govindan, R. & Stephenson, K. E. HIV vaccine development at a crossroads: new B and T\u2009cell approaches. Vaccines 12, 1043 (2024).","journal-title":"Vaccines"},{"key":"2549_CR10","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1126\/science.aan0662","volume":"355","author":"BF Haynes","year":"2017","unstructured":"Haynes, B. F. & Burton, D. R. Developing an HIV vaccine. Science 355, 1129\u20131130 (2017).","journal-title":"Science"},{"key":"2549_CR11","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1126\/science.aad9195","volume":"351","author":"JG Jardine","year":"2016","unstructured":"Jardine, J. G. et al. HIV-1 broadly neutralizing antibody precursor B\u2009cells revealed by germline-targeting immunogen. Science 351, 1458\u20131463 (2016).","journal-title":"Science"},{"key":"2549_CR12","doi-asserted-by":"publisher","first-page":"eaat0381","DOI":"10.1126\/scitranslmed.aat0381","volume":"10","author":"C Havenar-Daughton","year":"2018","unstructured":"Havenar-Daughton, C. et al. The human naive B\u2009cell repertoire contains distinct subclasses for a germline-targeting HIV-1 vaccine immunogen. Sci. Transl. Med. 10, eaat0381 (2018).","journal-title":"Sci. Transl. Med."},{"key":"2549_CR13","doi-asserted-by":"publisher","DOI":"10.1126\/science.aax4380","volume":"366","author":"JM Steichen","year":"2019","unstructured":"Steichen, J. M. et al. A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses. Science 366, eaax4380 (2019).","journal-title":"Science"},{"key":"2549_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00376-7","volume":"6","author":"JH Lee","year":"2021","unstructured":"Lee, J. H. et al. Vaccine genetics of IGHV1-2 VRC01-class broadly neutralizing antibody precursor na\u00efve human B\u2009cells. NPJ Vaccines 6, 113 (2021).","journal-title":"NPJ Vaccines"},{"key":"2549_CR15","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1126\/science.1234150","volume":"340","author":"J Jardine","year":"2013","unstructured":"Jardine, J. et al. Rational HIV immunogen design to target specific germline B cell receptors. Science 340, 711\u2013716 (2013).","journal-title":"Science"},{"key":"2549_CR16","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1084\/jem.20122824","volume":"210","author":"AT McGuire","year":"2013","unstructured":"McGuire, A. T. et al. Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies. J. Exp. Med. 210, 655\u2013663 (2013).","journal-title":"J. Exp. Med."},{"key":"2549_CR17","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.cell.2016.08.005","volume":"166","author":"B Briney","year":"2016","unstructured":"Briney, B. et al. Tailored immunogens direct affinity maturation toward HIV neutralizing antibodies. Cell 166, 1459\u20131470 (2016).","journal-title":"Cell"},{"key":"2549_CR18","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.immuni.2016.08.016","volume":"45","author":"JM Steichen","year":"2016","unstructured":"Steichen, J. M. et al. HIV vaccine design to target germline precursors of glycan-dependent broadly neutralizing antibodies. Immunity 45, 483\u2013496 (2016).","journal-title":"Immunity"},{"key":"2549_CR19","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.cell.2016.07.030","volume":"166","author":"A Escolano","year":"2016","unstructured":"Escolano, A. et al. Sequential immunization elicits broadly neutralizing anti-HIV-1 antibodies in Ig knockin mice. Cell 166, 1445\u20131458 (2016).","journal-title":"Cell"},{"key":"2549_CR20","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1084\/jem.20161160","volume":"214","author":"M Medina-Ram\u00edrez","year":"2017","unstructured":"Medina-Ram\u00edrez, M. et al. Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo. J. Exp. Med. 214, 2573\u20132590 (2017).","journal-title":"J. Exp. Med."},{"key":"2549_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.09.001","author":"JR Willis","year":"2022","unstructured":"Willis, J. R. et al. Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors. Immunity https:\/\/doi.org\/10.1016\/j.immuni.2022.09.001 (2022).","journal-title":"Immunity"},{"key":"2549_CR22","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.immuni.2020.12.014","volume":"54","author":"X Chen","year":"2021","unstructured":"Chen, X. et al. Vaccination induces maturation in a mouse model of diverse unmutated VRC01-class precursors to HIV-neutralizing antibodies with >50% breadth. Immunity 54, 324\u2013339 (2021).","journal-title":"Immunity"},{"key":"2549_CR23","doi-asserted-by":"publisher","DOI":"10.1126\/science.add6502","volume":"378","author":"DJ Leggat","year":"2022","unstructured":"Leggat, D. J. et al. Vaccination induces HIV broadly neutralizing antibody precursors in humans. Science 378, eadd6502 (2022).","journal-title":"Science"},{"key":"2549_CR24","doi-asserted-by":"publisher","first-page":"eadj8321","DOI":"10.1126\/science.adj8321","volume":"384","author":"JM Steichen","year":"2024","unstructured":"Steichen, J. M. et al. Vaccine priming of rare HIV broadly neutralizing antibody precursors in nonhuman primates. Science 384, eadj8321 (2024).","journal-title":"Science"},{"key":"2549_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adn0223","author":"CA Cottrell","year":"2024","unstructured":"Cottrell, C. A. et al. Heterologous prime-boost vaccination drives early maturation of HIV broadly neutralizing antibody precursors in humanized mice. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.adn0223 (2024).","journal-title":"Sci. Transl. Med."},{"key":"2549_CR26","doi-asserted-by":"publisher","first-page":"eadr8382","DOI":"10.1126\/science.adr8382","volume":"389","author":"JR Willis","year":"2025","unstructured":"Willis, J. R. et al. Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans. Science 389, eadr8382 (2025).","journal-title":"Science"},{"key":"2549_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/science.adv5572","author":"TG Caniels","year":"2025","unstructured":"Caniels, T. G. et al. Precise targeting of HIV broadly neutralizing antibody precursors in humans. Science https:\/\/doi.org\/10.1126\/science.adv5572 (2025).","journal-title":"Science"},{"key":"2549_CR28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2510163122","volume":"122","author":"X Lin","year":"2025","unstructured":"Lin, X. et al. Structural insights into VRC01-class bnAb precursors with diverse light chains elicited in the IAVI G001 human vaccine trial. Proc. Natl Acad. Sci. USA 122, e2510163122 (2025).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2549_CR29","doi-asserted-by":"publisher","first-page":"e1005815","DOI":"10.1371\/journal.ppat.1005815","volume":"12","author":"JG Jardine","year":"2016","unstructured":"Jardine, J. G. et al. Minimally mutated HIV-1 broadly neutralizing antibodies to guide reductionist vaccine design. PLoS Pathog. 12, e1005815 (2016).","journal-title":"PLoS Pathog."},{"key":"2549_CR30","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12861","author":"RK Abbott","year":"2020","unstructured":"Abbott, R. K. & Crotty, S. Factors in B\u2009cell competition and immunodominance. Immunol Rev https:\/\/doi.org\/10.1111\/imr.12861 (2020).","journal-title":"Immunol Rev"},{"key":"2549_CR31","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.chom.2012.09.008","volume":"12","author":"DR Burton","year":"2012","unstructured":"Burton, D. R. et al. A blueprint for HIV vaccine discovery. Cell Host Microbe 12, 396\u2013407 (2012).","journal-title":"Cell Host Microbe"},{"key":"2549_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/imr.12512","volume":"275","author":"C Havenar-Daughton","year":"2017","unstructured":"Havenar-Daughton, C., Lee, J. H. & Crotty, S. Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem. Immunol. Rev. 275, 49\u201361 (2017).","journal-title":"Immunol. Rev."},{"key":"2549_CR33","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1126\/science.adp3459","volume":"384","author":"RW Sanders","year":"2024","unstructured":"Sanders, R. W. & Moore, J. P. Progress on priming HIV-1 immunity. Science 384, 738\u2013739 (2024).","journal-title":"Science"},{"key":"2549_CR34","first-page":"a029389","volume":"10","author":"GD Victora","year":"2017","unstructured":"Victora, G. D. & Mouquet, H. What are the primary limitations in B-cell affinity maturation, and how much affinity maturation can we drive with vaccination?: lessons from the antibody response to HIV-1. CSH Perspect. Biol. 10, a029389 (2017).","journal-title":"CSH Perspect. Biol."},{"key":"2549_CR35","first-page":"a028803","volume":"10","author":"CT Stamper","year":"2017","unstructured":"Stamper, C. T. & Wilson, P. C. What are the primary limitations in B-cell affinity maturation, and how much affinity maturation can we drive with vaccination?: is affinity maturation a self-defeating process for eliciting broad protection? CSH Perspect. Biol. 10, a028803 (2017).","journal-title":"CSH Perspect. Biol."},{"key":"2549_CR36","first-page":"a029397","volume":"10","author":"G Kelsoe","year":"2018","unstructured":"Kelsoe, G. & Haynes, B. F. What are the primary limitations in b-cell affinity maturation, and how much affinity maturation can we drive with vaccination? Breaking through immunity\u2019s glass ceiling. CSH Perspect. Biol. 10, a029397 (2018).","journal-title":"CSH Perspect. Biol."},{"key":"2549_CR37","doi-asserted-by":"publisher","first-page":"eadk0582","DOI":"10.1126\/science.adk0582","volume":"384","author":"Z Xie","year":"2024","unstructured":"Xie, Z. et al. mRNA-LNP HIV-1 trimer boosters elicit precursors to broad neutralizing antibodies. Science 384, eadk0582 (2024).","journal-title":"Science"},{"key":"2549_CR38","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1084\/jem.20120150","volume":"210","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y. et al. Germinal center B cells govern their own fate via antibody feedback. J. Exp. Med. 210, 457\u2013464 (2013).","journal-title":"J. Exp. Med."},{"key":"2549_CR39","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1016\/j.immuni.2022.07.020","volume":"55","author":"JMJ Tas","year":"2022","unstructured":"Tas, J. M. J. et al. Antibodies from primary humoral responses modulate recruitment of naive B cells during secondary responses. Immunity 55, 1856\u20131871 (2022).","journal-title":"Immunity"},{"key":"2549_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2024.08.017","author":"AR Dvorscek","year":"2024","unstructured":"Dvorscek, A. R. et al. Conversion of vaccines from low to high immunogenicity by antibodies with epitope complementarity. Immunity https:\/\/doi.org\/10.1016\/j.immuni.2024.08.017 (2024).","journal-title":"Immunity"},{"key":"2549_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2024.05.009","author":"A Schiepers","year":"2024","unstructured":"Schiepers, A. et al. Opposing effects of pre-existing antibody and memory T cell help on the dynamics of recall germinal centers. Immunity https:\/\/doi.org\/10.1016\/j.immuni.2024.05.009 (2024).","journal-title":"Immunity"},{"key":"2549_CR42","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.immuni.2024.06.009","volume":"57","author":"JG Cyster","year":"2024","unstructured":"Cyster, J. G. & Wilson, P. C. Antibody modulation of B cell responses\u2014incorporating positive and negative feedback. Immunity 57, 1466\u20131481 (2024).","journal-title":"Immunity"},{"key":"2549_CR43","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cell.2019.11.032","volume":"180","author":"L Mesin","year":"2019","unstructured":"Mesin, L. et al. Restricted clonality and limited germinal center reentry characterize memory B cell reactivation by boosting. Cell 180, 92\u2013106 (2019).","journal-title":"Cell"},{"key":"2549_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abn5311","volume":"7","author":"M Kuraoka","year":"2022","unstructured":"Kuraoka, M. et al. Recall of B cell memory depends on relative locations of prime and boost immunization. Sci. Immunol. 7, eabn5311 (2022).","journal-title":"Sci. Immunol."},{"key":"2549_CR45","first-page":"a029405","volume":"10","author":"MJ Shlomchik","year":"2018","unstructured":"Shlomchik, M. J. Do memory B cells form secondary germinal centers? Yes and no. CSH Perspect. Biol. 10, a029405 (2018).","journal-title":"CSH Perspect. Biol."},{"key":"2549_CR46","first-page":"a028878","volume":"10","author":"LJ McHeyzer-Williams","year":"2018","unstructured":"McHeyzer-Williams, L. J., Dufaud, C. & McHeyzer-Williams, M. G. Do memory B cells form secondary germinal centers? Impact of antibody class and quality of memory T-cell help at recall. CSH Perspect. Biol. 10, a028878 (2018).","journal-title":"CSH Perspect. Biol."},{"key":"2549_CR47","first-page":"a029116","volume":"10","author":"KA Pape","year":"2017","unstructured":"Pape, K. A. & Jenkins, M. K. Do memory B cells form secondary germinal centers?: it depends. CSH Perspect. Biol. 10, a029116 (2017).","journal-title":"CSH Perspect. Biol."},{"key":"2549_CR48","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1126\/science.1192819","volume":"329","author":"T Zhou","year":"2010","unstructured":"Zhou, T. et al. Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science 329, 811\u2013817 (2010).","journal-title":"Science"},{"key":"2549_CR49","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1126\/science.1187659","volume":"329","author":"X Wu","year":"2010","unstructured":"Wu, X. et al. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science 329, 856\u2013861 (2010).","journal-title":"Science"},{"key":"2549_CR50","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.cell.2016.07.029","volume":"166","author":"M Tian","year":"2016","unstructured":"Tian, M. et al. Induction of HIV neutralizing antibody lineages in mice with diverse precursor repertoires. Cell 166, 1471\u20131484 (2016).","journal-title":"Cell"},{"key":"2549_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110485","volume":"38","author":"JH Lee","year":"2022","unstructured":"Lee, J. H. et al. Highly mutated antibodies capable of neutralizing N276 glycan-deficient HIV after a single immunization with an Env trimer. Cell Rep. 38, 110485 (2022).","journal-title":"Cell Rep."},{"key":"2549_CR52","doi-asserted-by":"publisher","first-page":"101003","DOI":"10.1016\/j.xcrm.2023.101003","volume":"4","author":"TG Caniels","year":"2023","unstructured":"Caniels, T. G. et al. Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertions. Cell Rep. Med. 4, 101003 (2023).","journal-title":"Cell Rep. Med."},{"key":"2549_CR53","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1126\/science.1207227","volume":"333","author":"JF Scheid","year":"2011","unstructured":"Scheid, J. F. et al. Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science 333, 1633\u20131637 (2011).","journal-title":"Science"},{"key":"2549_CR54","doi-asserted-by":"publisher","first-page":"E2083","DOI":"10.1073\/pnas.1208984109","volume":"109","author":"AP West","year":"2012","unstructured":"West, A. P., Diskin, R., Nussenzweig, M. C. & Bjorkman, P. J. Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120. Proc. Natl Acad. Sci. USA 109, E2083\u2013E2090 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2549_CR55","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.immuni.2013.04.012","volume":"39","author":"T Zhou","year":"2013","unstructured":"Zhou, T. et al. Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies. Immunity 39, 245\u2013258 (2013).","journal-title":"Immunity"},{"key":"2549_CR56","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1126\/science.aac5894","volume":"349","author":"JG Jardine","year":"2015","unstructured":"Jardine, J. G. et al. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen. Science 349, 156\u2013161 (2015).","journal-title":"Science"},{"key":"2549_CR57","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.immuni.2017.11.023","volume":"48","author":"RK Abbott","year":"2018","unstructured":"Abbott, R. K. et al. Precursor frequency and affinity determine B cell competitive fitness in germinal centers, tested with germline-targeting HIV vaccine immunogens. Immunity 48, 133\u2013146 (2018).","journal-title":"Immunity"},{"key":"2549_CR58","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41591-020-0753-3","volume":"26","author":"TJ Moyer","year":"2020","unstructured":"Moyer, T. J. et al. Engineered immunogen binding to alum adjuvant enhances humoral immunity. Nat. Med. 26, 430\u2013440 (2020).","journal-title":"Nat. Med."},{"key":"2549_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.08.001","author":"Y Kato","year":"2020","unstructured":"Kato, Y. et al. Multifaceted effects of antigen valency on B cell response composition and differentiation in vivo. Immunity https:\/\/doi.org\/10.1016\/j.immuni.2020.08.001 (2020).","journal-title":"Immunity"},{"key":"2549_CR60","doi-asserted-by":"publisher","first-page":"e20201254","DOI":"10.1084\/jem.20201254","volume":"218","author":"JH Lee","year":"2020","unstructured":"Lee, J. H. et al. Modulating the quantity of HIV Env-specific CD4 T cell help promotes rare B cell responses in germinal centers. J. Exp. Med. 218, e20201254 (2020).","journal-title":"J. Exp. Med."},{"key":"2549_CR61","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abf1152","volume":"6","author":"M Silva","year":"2021","unstructured":"Silva, M. et al. A particulate saponin\/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immunity. Sci. Immunol. 6, eabf1152 (2021).","journal-title":"Sci. Immunol."},{"key":"2549_CR62","doi-asserted-by":"publisher","unstructured":"Weidner, N. G. et al. Antigen avidity drives the durability of the vaccine immune response. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.04.18.649567 (2025).","DOI":"10.1101\/2025.04.18.649567"},{"key":"2549_CR63","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.cell.2019.04.012","volume":"177","author":"KM Cirelli","year":"2019","unstructured":"Cirelli, K. M. et al. Slow delivery immunization enhances HIV neutralizing antibody and germinal center responses via modulation of immunodominance. Cell 177, 1153\u20131171 (2019).","journal-title":"Cell"},{"key":"2549_CR64","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/s41586-022-05216-9","volume":"609","author":"JH Lee","year":"2022","unstructured":"Lee, J. H. et al. Long-primed germinal centres with enduring affinity maturation and clonal migration. Nature 609, 998\u20131004 (2022).","journal-title":"Nature"},{"key":"2549_CR65","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adl3755","volume":"9","author":"SH Bhagchandani","year":"2024","unstructured":"Bhagchandani, S. H. et al. Two-dose priming immunization amplifies humoral immunity by synchronizing vaccine delivery with the germinal center response. Sci. Immunol. 9, eadl3755 (2024).","journal-title":"Sci. Immunol."},{"key":"2549_CR66","doi-asserted-by":"publisher","first-page":"E6639","DOI":"10.1073\/pnas.1606050113","volume":"113","author":"HH Tam","year":"2016","unstructured":"Tam, H. H. et al. Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination. Proc. Natl Acad. Sci. USA 113, E6639\u2013E6648 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2549_CR67","doi-asserted-by":"publisher","first-page":"10383","DOI":"10.1128\/JVI.01653-15","volume":"89","author":"JK Hu","year":"2015","unstructured":"Hu, J. K. et al. Murine antibody responses to cleaved soluble HIV-1 envelope trimers are highly restricted in specificity. J. Virol. 89, 10383\u201310398 (2015).","journal-title":"J. Virol."},{"key":"2549_CR68","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.immuni.2025.03.003","volume":"58","author":"PJ Madden","year":"2025","unstructured":"Madden, P. J. et al. Diverse priming outcomes under conditions of very rare precursor B cells. Immunity 58, 997\u20131014 (2025).","journal-title":"Immunity"},{"key":"2549_CR69","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.cell.2019.12.027","volume":"180","author":"KM Cirelli","year":"2020","unstructured":"Cirelli, K. M. et al. Slow delivery immunization enhances HIV neutralizing antibody and germinal center responses via modulation of immunodominance. Cell 180, 206 (2020).","journal-title":"Cell"},{"key":"2549_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-020-00223-1","volume":"5","author":"JT Martin","year":"2020","unstructured":"Martin, J. T. et al. Targeting HIV Env immunogens to B cell follicles in nonhuman primates through immune complex or protein nanoparticle formulations. NPJ Vaccines 5, 72 (2020).","journal-title":"NPJ Vaccines"},{"key":"2549_CR71","doi-asserted-by":"publisher","first-page":"eadw0721","DOI":"10.1126\/scitranslmed.adw0721","volume":"17","author":"P Ramezani-Rad","year":"2025","unstructured":"Ramezani-Rad, P. et al. Vaccination with mRNA-encoded membrane-bound HIV envelope trimer induces neutralizing antibodies in animal models. Sci. Transl. Med. 17, eadw0721 (2025).","journal-title":"Sci. Transl. Med."},{"key":"2549_CR72","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ady6831","volume":"17","author":"KR Parks","year":"2025","unstructured":"Parks, K. R. et al. Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial. Sci. Transl. Med. 17, eady6831 (2025).","journal-title":"Sci. Transl. Med."},{"key":"2549_CR73","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1016\/j.cell.2019.11.003","volume":"179","author":"I Setliff","year":"2019","unstructured":"Setliff, I. et al. High-throughput mapping of B cell receptor sequences to antigen specificity. Cell 179, 1636\u20131646 (2019).","journal-title":"Cell"},{"key":"2549_CR74","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.immuni.2019.06.004","volume":"51","author":"J Umotoy","year":"2019","unstructured":"Umotoy, J. et al. Rapid and focused maturation of a VRC01-class HIV broadly neutralizing antibody lineage involves both binding and accommodation of the N276-glycan. Immunity 51, 141\u2013154 (2019).","journal-title":"Immunity"},{"key":"2549_CR75","doi-asserted-by":"publisher","first-page":"115713","DOI":"10.1016\/j.celrep.2025.115713","volume":"44","author":"K-MA Dam","year":"2025","unstructured":"Dam, K.-M. A. et al. Mapping essential somatic hypermutations in a CD4-binding site bNAb informs HIV-1 vaccine design. Cell Rep. 44, 115713 (2025).","journal-title":"Cell Rep."},{"key":"2549_CR76","doi-asserted-by":"publisher","first-page":"109922","DOI":"10.1016\/j.celrep.2021.109922","volume":"37","author":"CA Cottrell","year":"2021","unstructured":"Cottrell, C. A. et al. Structural basis of glycan276-dependent recognition by HIV-1 broadly neutralizing antibodies. Cell Rep. 37, 109922 (2021).","journal-title":"Cell Rep."},{"key":"2549_CR77","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.cell.2015.05.007","volume":"161","author":"T Zhou","year":"2015","unstructured":"Zhou, T. et al. Structural repertoire of HIV-1-neutralizing antibodies targeting the CD4 supersite in 14 donors. Cell 161, 1280\u20131292 (2015).","journal-title":"Cell"},{"key":"2549_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.07.001","author":"HA McNamara","year":"2020","unstructured":"McNamara, H. A. et al. Antibody feedback limits the expansion of B cell responses to malaria vaccination but drives diversification of the humoral response. Cell Host Microbe https:\/\/doi.org\/10.1016\/j.chom.2020.07.001 (2020).","journal-title":"Cell Host Microbe"},{"key":"2549_CR79","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41586-023-05715-3","volume":"615","author":"A Schiepers","year":"2023","unstructured":"Schiepers, A. et al. Molecular fate-mapping of serum antibody responses to repeat immunization. Nature 615, 482\u2013489 (2023).","journal-title":"Nature"},{"key":"2549_CR80","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1038\/s41590-023-01559-1","volume":"24","author":"A Mart\u00ednez-Ria\u00f1o","year":"2023","unstructured":"Mart\u00ednez-Ria\u00f1o, A. et al. Long-term retention of antigens in germinal centers is controlled by the spatial organization of the follicular dendritic cell network. Nat. Immunol. 24, 1281\u20131294 (2023).","journal-title":"Nat. Immunol."},{"key":"2549_CR81","doi-asserted-by":"publisher","DOI":"10.1126\/science.abn8934","volume":"379","author":"A Aung","year":"2023","unstructured":"Aung, A. et al. Low protease activity in B cell follicles promotes retention of intact antigens after immunization. Science 379, eabn8934 (2023).","journal-title":"Science"},{"key":"2549_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01549-6","volume":"8","author":"DW Kulp","year":"2017","unstructured":"Kulp, D. W. et al. Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding. Nat. Commun. 8, 1655 (2017).","journal-title":"Nat. Commun."}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02549-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02549-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02549-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T22:02:57Z","timestamp":1782684177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02549-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":82,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2549"],"URL":"https:\/\/doi.org\/10.1038\/s41590-026-02549-9","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.J.I. and S.C. are inventors on a patent related to SMNP adjuvant (US11,547,672). W.R.S. is an inventor on patent applications related to immunogens in this manuscript filed by The Scripps Research Institute and IAVI. W.R.S. is an employee and shareholder of Moderna, Inc. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}